---
author: []
related: []
publisher:
  url: 'http://www.reuters.com'
  name: Reuters
  favicon: 'http://s3.reutersmedia.net/resources_v2/images/favicon.ico'
  domain: www.reuters.com
keywords: []
description: 'TEL AVIV Already a pioneer in high-tech and cutting-edge agriculture, Israel is starting to attract American companies looking to bring medical marijuana know-how to a booming market back home. Since 2014, U.S. firms have invested about $50 million in licensing Israeli medical marijuana patents, cannabis agro-tech startups and firms developing delivery devices such as inhalers, said Saul Kaye, CEO of iCAN, a private cannabis research hub.'
app_links: []
isBasedOnUrl: 'http://www.reuters.com/article/us-israel-cannabis-idUSKCN0WV1KD'
title: 'U.S. firms target investment in Israeli cannabis R&D'
datePublished: '2016-03-31T19:25:49.988Z'
dateModified: '2016-03-31T19:19:19.879Z'
sourcePath: _posts/2016-03-31-us-firms-target-investment-in-israeli-cannabis-randd.md
published: true
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>U.S. firms target investment in Israeli cannabis R&amp;D</h1><p>TEL AVIV Already a pioneer in high-tech and cutting-edge agriculture, Israel is starting to attract American companies looking to bring medical marijuana know-how to a booming market back home. Since 2014, U.S. firms have invested about $50 million in licensing Israeli medical marijuana patents, cannabis agro-tech startups and firms developing delivery devices such as inhalers, said Saul Kaye, CEO of iCAN, a private cannabis research hub.</p><img src="http://s3.reutersmedia.net/resources/r/?m=02&amp;d=20160329&amp;t=2&amp;i=1128645895&amp;w=&amp;fh=545px&amp;fw=&amp;ll=&amp;pl=&amp;sq=&amp;r=LYNXNPEC2S0T6" /></article>